InvestorsHub Logo
Followers 17
Posts 13856
Boards Moderated 1
Alias Born 11/18/2003

Re: Arctec post# 11612

Tuesday, 02/06/2007 9:09:19 PM

Tuesday, February 06, 2007 9:09:19 PM

Post# of 11715
Ear on the Street

Aeroplan Income Fund (AER.UN : TSX : $19.70)
Air Mile business reports strong Q4
Blackmont Capital maintains "sell", 12-month target price is $12.50

Alamos Gold Inc. (AGI : TSX : $8.32)
Escondida resource upgrade in line
RBC Capital Markets maintains "sector perform", 12-month target price is $11.00

Agrium (AGU : TSX : $42.04 | NYSE : US$35.45)
Q4 slightly lower than expected
RBC Capital Markets maintains "sector perform", 12-month target price is US$37.00

Angiotech Pharmaceuticals (ANP : TSX : $8.84 | ANPI : NASDAQ : US$7.45)
Q4 slightly misses and 2007 guidance significantly reduced
Blackmont Capital downgrades to "hold", 12-month target price is cut to US$9.00
CIBC World Markets maintains "sector outperform", 12-month target price is cut to US$11.50
Desjardins Securities maintains "hold", 12-month target price is cut to US$10.00
RBC Capital Markets maintains "outperform", 12-month target price is US$13.00
TD Newcrest maintains "hold", 12-month target price is cut to US$7.50

ATS Automation Tooling Systems (ATA : TSX : $12.53)
May face profit taking in the near term
CIBC World Markets maintains "sector outperform", 12-month target price is cut to $16.50

Bell Aliant (BA.UN : TSX : $29.35)
Q4 in line and dividend hiked by 3%
RBC Capital Markets maintains "sector perform", 12-month target price is $29.00

Brookfield Properties (BPO : TSX : $55.81 | NYSE : US$47.09)
Downgrade on valuation
TD Newcrest downgrades to "hold", 12-month target price is raised to US$46.00

Bow Valley Energy (BVX : TSX : $6.55)
Acquires more working interests in the U.K. North Sea
Blackmont Capital maintains "buy", 12-month target price is $7.50

Calian Technologies (CTY : TSX : $13.47)
Q1 essentially in line
Desjardins Securities maintains "hold", 12-month target price is $14.50

Eldorado Gold (ELD : TSX : $6.89)
No suprises in Q4 production
Blackmont Capital maintains "hold", 12-month target price is $7.00

Great-West Lifeco (GWO : TSX : $34.96)
Acquires Putnam Investments
Credit Suisse maintains "neutral", 12-month target price is $35.00
Desjardins Securities maintains "buy", 12-month target price is $36.00
GMP Securities maintains "buy", 12-month target price is $41.00
TD Newcrest upgrades to "hold", 12-month target price is raised to $36.00

Imperial Oil (IMO : TSX : $42.09)
Mackenzie pipeline hearings continue
CIBC World Markets maintains "sector performer", 12-month target price is raised to $45.00
Credit Suisse First Boston rates "underperform", 12-month target price is $44.00
RBC Capital Markets rate "sector perform", 12-month target price is $40.00
TD Newcrest maintains "action list buy", 12-month target price is $48.00

Loblaw Companies (L : TSX : $51.79)
Restructuring plan expected
TD Newcrest maintains "reduce", 12-month target price is $48.00

Lundin Mining (LUN : TSX : $12.99)
Prices reflect 3-for-1 split
CIBC World Markets maintains "sector outperformer", 12-month target price is $17.00

Miramar Mining (MAE : TSX : $5.23)
Owns Hope Bay gold
RBC Capital Markets initiates coverage with "sector perform", 12-month target price is $6.00

Manitoba Telecom Services (MBT : TSX : $47.61)
Takeover target
RBC Capital Markets rate "outperform", 12-month target price is $54.00

Melcor Developments (MRD : TSX : $19.70)
Soaring Alberta property values
Desjardins Securities maintains "top pick", 12-month target price is increased to $33.15

Norbord Inc. (NBD : TSX : $9.63)
Q4/06 results reported
Desjardins Securities maintains "hold", 12-month target price is increased to $9.25
RBC Capital Markets maintains "sector perform", 12-month target price is $9.50
TD Newcrest maintains "buy", 12-month target price is $11.00

Neurochem (NRM : TSX : $20.02)
Phase III trial completed
RBC Capital Markets rates "underperform", 12-month target price is $13.00

Jean Coutu Group (PJC) (PJC.A : TSX : $15.42)
Quebec government announces preliminary changes to drug reimbursement program
RBC Capital Markets maintains a "sector perform", target price is $16.00

Potash Corp. of Saskatchewan (POT : TSX : $186.27 | NYSE : US$156.97)
Rumours coming out concerning Chinese potash negotiations
RBC Capital Markets maintains a "outperform", target price is US$165.00

Rothmans Inc. (ROC : TSX : $21.12)
Q3 in line
Blackmont Capital maintains "hold", 12-month target price is $21.00

Saputo Inc. (SAP : TSX : $38.03)
Q3 results coming tomorrow
CIBC World Markets maintains a "sector perform", target price is $37.00

Sears Canada (SCC : TSX : $27.28)
Fourth quarter miss due to unseasonable weather
CIBC World Markets maintains "sector underperformer", 12-month target price is raised to $24.00
RBC Capital Markets maintains a "underperform", target price is $22.00

Tembec Inc. (TBC : TSX : $2.81)
First quarter results below expectations
CIBC World Markets maintains a "sector underperform", target price is $0.75
Desjardins Securities maintains a "sell", target price is $1.25
RBC Capital Markets maintains a "underperform", target price is $0.00
TD Newcrest maintains a "reduce", 12-month target price is $1.25

TIO Networks (TNC : TSX-V : $0.95)
Major expansion of ExxonMobil's eWiz program expected in 2007
GMP Securities maintains "buy", 12-month target price is $1.70

Transition Therapeutics Inc (TTH : TSX : $1.80)
Phase II diabetes results expected this month
GMP Securities reiterates "buy", target price is $2.85

Tundra Semiconductor (TUN : TSX : $9.76)
Sale of RioLabs
Blackmont Capital maintains "hold", 12-month target price is $13.00





Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.